Two Sigma Investments, LP Genocea Biosciences, Inc. Transaction History

Two Sigma Investments, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$0.95 - $1.99 $54,944 - $115,093	-57,836 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$1.74 - $2.33 $168,103 - $225,103	-96,611 Reduced 62.55%	57,836 $111,000
Q2 2021 Aug 16, 2021	SELL	$2.06 - $2.82 $483,197 - $661,464	-234,562 Reduced 60.3%	154,447 $361,000
Q1 2021 May 17, 2021	BUY	$2.35 - $4.01 $93,447 - $159,457	39,765 Added 11.39%	389,009 $1.05 Million
Q4 2020 Feb 16, 2021	BUY	$1.91 - $2.67 $319,416 - $446,514	167,234 Added 91.88%	349,244 $845,000
Q3 2020 Nov 16, 2020	BUY	$1.81 - $5.53 $329,438 - $1.01 Million	182,010 New	182,010 $417,000
Q1 2020 May 15, 2020	SELL	$1.26 - $2.73 $27,641 - $59,890	-21,938 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$2.05 - $2.82 $44,972 - $61,865	21,938 New	21,938 $45,000

10K

Ticker GNCA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,783,500
Description
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.